U.S. COVID-19 booster rollout to initially proceed with just Pfizer vaccine: Sources

Moderna Inc's booster submission was found inadequate and the U.S. Food and Drug Administration requires stronger data from the company, making the process likely to be a few weeks behind that of Pfizer/BioNTech, the source added.

Agencies
The U.S government's plan to roll out additional shots of the COVID-19 vaccine for the general public on Sept. 20 will proceed with just the Pfizer /BioNTech SE vaccine, a source familiar with the discussion said on Friday.

Moderna Inc's booster submission was found inadequate and the U.S. Food and Drug Administration requires stronger data from the company, making the process likely to be a few weeks behind that of Pfizer/BioNTech, the source added.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › World News › U.S. COVID-19 booster rollout to initially proceed with just Pfizer vaccine: Sources
Text Size:AAA
Success
This article has been saved

*

+